Subcutaneous Mucormycosis

Subcutaneous (cutaneous) mucormycosis is a very dangerous acute or subacute necrotizing fungal infection caused by molds of the order Mucorales. Unlike other subcutaneous mycoses that progress slowly (such as phaeohyphomycosis or lobomycosis), Mucorales are extremely aggressive because they invade blood vessels directly (angioinvasion). This causes clotting, vessel blockage and rapidly spreading ischemic necrosis.

Although cutaneous and subcutaneous disease generally has better survival than the rhinocerebral or pulmonary forms, it is still a MEDICAL EMERGENCY. At Haute-Derma, managing subcutaneous mucormycosis requires fast coordination of immediate biopsy diagnosis, radical surgical removal of dead tissue and high-dose systemic antifungal therapy.

Microbiology and Pathogenesis

Main Causative Organisms

The infection is caused by molds in the order Mucorales:

Rhizopus spp. (especially Rhizopus arrhizus / Rhizopus oryzae): the most commonly isolated cause.
Lichtheimia spp. (formerly Absidia), Mucor spp. and Apophysomyces variabilis (which often infects people with normal immunity after severe trauma or natural disasters).

Microscopic Features

Mucorales hyphae in tissue have very distinctive features:

Very broad (5–20 µm), flat, wrinkled, ribbon-like hyphae.
No septa (aseptate or coenocytic), or only a few pseudosepta.
Irregular branching at wide angles (70°–90°, close to right angles).

How the Fungus Invades Vessels and Kills Tissue

Route of entry: Spores enter through open wounds, burns, puncture wounds, surgical sites or crushed skin.
Vessel wall invasion: Hyphae attach to endothelial cells through the GRP78 receptor, then push through the walls of arteries and veins in the dermis and subcutis.
Vessel blockage and black necrosis: The hyphae trigger clotting, forming fungal thrombi that completely cut off the blood supply. Within a few days the whole area of skin and underlying tissue turns into black, dead tissue (eschar).

Main Clinical Forms

Acute Necrotizing Form — the most common: It begins as a dark red, tender, burning patch that quickly develops hemorrhagic blisters on the surface. Within 24–48 hours the center turns into a dry black eschar, with a swollen, red border that spreads outward very rapidly.
Subacute (Chronic) Nodular Form: Usually seen in people with normal immunity or mildly uncontrolled diabetes. It appears as firm, rubbery nodules under the skin that progress more slowly and are easily confused with other necrotizing fungal infections or chronic bacterial abscesses.
Deep Invasive / Disseminated Form: The fungus breaks through the deep fascia into the underlying muscle and bone (causing tendon inflammation and necrotizing myositis), or spreads through the bloodstream to the lungs, brain and other organs.

Our Diagnostic Workup at Haute-Derma

Immediate Direct Microscopy (KOH / Calcofluor White):

Technique: scraping or smearing necrotic material or tissue from the edge of the lesion.
Findings: flat, ribbon-like, thin-walled, aseptate hyphae branching at right angles (90°). This is enough to start emergency treatment immediately without waiting for culture.

Urgent Biopsy (Frozen Section / Histopathology):

H&E stain: Widespread ischemic necrosis and infarction of the dermis and subcutis. Hyphae fill the lumens of necrotic vessels (angioinvasion) and spread into the surrounding tissue.
GMS stain (Grocott's methenamine silver): Hyphae stain deep black, clearly showing their broad, flat, aseptate structure.

Fungal Culture:

Biopsy tissue must NOT be homogenized or ground, because breaking the aseptate hyphae lets their cytoplasm leak out, killing the fungus and causing a false-negative culture.
The tissue is gently minced with a scalpel and placed directly on Sabouraud dextrose agar (SDA) without cycloheximide, then incubated at 28°C and 37°C. Growth is very fast (24–48 hours), producing fluffy gray-white colonies.

Emergency Multimodal Treatment at Haute-Derma

Radical Surgical Debridement

All dead tissue is removed back to healthy, well-perfused margins. Haute-Derma surgeons may need to repeat debridement every 24–48 hours (serial debridements) until frozen-section biopsies of the margins no longer show hyphae.

Emergency Systemic Antifungal Therapy

Liposomal amphotericin B (L-AmB) — first choice (gold standard):
- Dose: 5–10 mg/kg/day intravenously, much higher than for routine fungal infections, so that enough drug reaches tissue with blocked vessels.
Posaconazole / isavuconazole:
- Indications: oral step-down therapy once the disease is controlled with L-AmB, or as an alternative when amphotericin B causes serious toxicity (isavuconazole IV/oral: 200 mg three times daily for the first 2 days, then 200 mg/day).

Correcting Underlying Conditions (Medical Reversal)

Control blood sugar and fully treat diabetic ketoacidosis. An acidic environment and high levels of free iron in the blood strongly fuel the growth of Rhizopus.
Stop, or reduce as far as possible, immunosuppressive drugs and systemic corticosteroids.

Frequently Asked Questions (FAQs)

+Why is subcutaneous mucormycosis treated as a MEDICAL EMERGENCY, unlike other subcutaneous fungal infections?

Unlike slow-growing subcutaneous fungi (such as Exophiala or Lacazia), Mucorales release enzymes that break down blood vessels and bind to the GRP78 receptor on endothelial cells. They invade the vessel lumen directly and form fungal clots that block the vessels feeding the tissue. As a result, tissue dies very quickly, at a rate of several centimeters a day. Without urgent debridement and medication, the fungus invades muscle and bone or enters the bloodstream, causing septic shock and death.

+Why must a biopsy suspected of mucormycosis NOT be minced finely or homogenized before culture?

+How do subcutaneous mucormycosis and subcutaneous basidiobolomycosis differ in appearance and treatment response?

Although both are caused by broad-hyphae fungi (once grouped together as zygomycosis), they are very different:

Mucormycosis: Aseptate hyphae that invade blood vessels and cause black necrosis; very rapid course; responds to amphotericin B and posaconazole but not to older azoles.
Basidiobolomycosis (entomophthoramycosis): Hyphae surrounded by the Splendore-Hoeppli phenomenon (eosinophilic material deposited around the fungus); does NOT invade blood vessels; forms a hard, fibrotic mass without necrosis; chronic course; responds very well to itraconazole or potassium iodide (KI) but is resistant to amphotericin B.